Obstructive sleep apnea and cardiometabolic risk
Obstructive sleep apnea (OSA) is a chronic, progressive disorder with a high prevalence in the population. Without timely diagnosis and therapy OSA can significantly affect the quality of life of the patients. OSA is a common co-morbidity in patients with metabolic syndrome (MS) and cardiovascular d...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | srp |
| Published: |
Pharmaceutical Association of Serbia, Belgrade, Serbia
2019-01-01
|
| Series: | Arhiv za farmaciju |
| Subjects: | |
| Online Access: | https://scindeks-clanci.ceon.rs/data/pdf/0004-1963/2019/0004-19631903153V.pdf |